(Q37486214)

20 August 2017

1 reference

title

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation (English)

1 reference

20 August 2017

0 references

0 references

0 references

1 reference

2

Frauke Zipp

1 reference

20 August 2017

Olaf Hoffmann

1

1 reference

20 August 2017

Joerg R Weber

series ordinal

3

1 reference

20 August 2017

publication date

17 May 2009

1 reference

Journal of Molecular Medicine

20 August 2017

published in

1 reference

20 August 2017

volume

87

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

753-763

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-009-0484-x

20 August 2017

exact match

0 references

cites work

Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Acceleration of human neutrophil apoptosis by TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Human NK cells lyse organ-specific endothelial cells: analysis of adhesion and cytotoxic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-009-0484-X

Death to the bad guys: targeting cancer via Apo2L/TRAIL.

21 January 2018

1 reference

12 December 2020

The receptor for the cytotoxic ligand TRAIL

1 reference

12 December 2020

Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis.

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression

1 reference

12 December 2020

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

12 December 2020

Requirement of caspases and p38 MAPK for TRAIL-mediated ICAM-1 expression by human astroglial cells

1 reference

12 December 2020

Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.

1 reference

12 December 2020

p38 mitogen-activated protein kinase modulates expression of tumor necrosis factor-related apoptosis-inducing ligand induced by interferon-gamma in fetal brain astrocytes.

1 reference

12 December 2020

Following a TRAIL: update on a ligand and its five receptors

1 reference

12 December 2020

Reprogramming the host response in bacterial meningitis: how best to improve outcome?

1 reference

12 December 2020

TRAIL is expressed in the brain cells of Alzheimer's disease patients

1 reference

12 December 2020

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

12 December 2020

1 reference

12 December 2020

Normal thymocyte negative selection in TRAIL-deficient mice

1 reference

12 December 2020

The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases

1 reference

12 December 2020

Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat.

1 reference

12 December 2020

Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions

1 reference

12 December 2020

Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia

1 reference

12 December 2020

T-lymphocyte entry into the central nervous system

1 reference

12 December 2020

Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils.

1 reference

12 December 2020

Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage

1 reference

12 December 2020

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

1 reference

12 December 2020

Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia

1 reference

12 December 2020

Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice

1 reference

12 December 2020

FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier.

1 reference

12 December 2020

Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis

1 reference

12 December 2020

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

12 December 2020

Cytotoxicity of TRAIL/anticancer drug combinations in human normal cells

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection

1 reference

12 December 2020

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

1 reference

12 December 2020

Glial cell influence on the human blood-brain barrier

1 reference

12 December 2020

Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

1 reference

12 December 2020

Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1

1 reference

12 December 2020

Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity

1 reference

12 December 2020

The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase

1 reference

12 December 2020

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

1 reference

12 December 2020

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

12 December 2020

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

1 reference

12 December 2020

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

1 reference

12 December 2020

TRAIL-R as a negative regulator of innate immune cell responses.

1 reference

12 December 2020

TRAIL induces death of human oligodendrocytes isolated from adult brain

1 reference

12 December 2020

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.

1 reference

12 December 2020

TRAIL and NFkappaB signaling--a complex relationship

1 reference

12 December 2020

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

12 December 2020

TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes

1 reference

12 December 2020

Death receptor expression and function at the human blood brain barrier.

1 reference

12 December 2020

TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis

1 reference

12 December 2020

Astrocyte-induced T cell elimination is CD95 ligand dependent.

1 reference

12 December 2020

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

12 December 2020

Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies

1 reference

12 December 2020

Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke

1 reference

12 December 2020

Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

1 reference

12 December 2020

Neuronal FasL induces cell death of encephalitogenic T lymphocytes

1 reference

12 December 2020

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

12 December 2020

Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.

1 reference

12 December 2020

CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons.

1 reference

12 December 2020

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

12 December 2020

Defining characteristics of Types I and II apoptotic cells in response to TRAIL.

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells

1 reference

12 December 2020

TRAIL limits excessive host immune responses in bacterial meningitis

1 reference

12 December 2020

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice

1 reference

12 December 2020

Biochemistry and function of the DISC

1 reference

12 December 2020

HIV infection and dementia

1 reference

12 December 2020

Phosphatidylinositol 3-kinase activation and interaction with focal adhesion kinase in Escherichia coli K1 invasion of human brain microvascular endothelial cells

1 reference

12 December 2020

Hypoxia-inducible factor-2alpha regulates the expression of TRAIL receptor DR5 in renal cancer cells

1 reference

12 December 2020

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

1 reference

12 December 2020

Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis.

1 reference

12 December 2020

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

1 reference

12 December 2020

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

12 December 2020

Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis

1 reference

12 December 2020

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

12 December 2020

Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria

1 reference

12 December 2020

Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators

1 reference

12 December 2020

Apoptosis signaling by death receptors.

1 reference

12 December 2020

Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.

1 reference

12 December 2020

Reovirus-induced apoptosis is mediated by TRAIL

1 reference

12 December 2020

On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.

1 reference

12 December 2020

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

12 December 2020

Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l

1 reference

12 December 2020

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

1 reference

12 December 2020

PI-3K/Akt and NF-?B/I?B? pathways are activated in Jurkat T cells in response to TRAIL treatment

1 reference

12 December 2020

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

1 reference

12 December 2020

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation

1 reference

12 December 2020

Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)

1 reference

12 December 2020

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

12 December 2020

Axonal damage in acute multiple sclerosis lesions.

1 reference

12 December 2020

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

1 reference

12 December 2020

Neuronal injury in bacterial meningitis: mechanisms and implications for therapy

1 reference

12 December 2020

HIV-1 infection and AIDS: consequences for the central nervous system

1 reference

12 December 2020

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

12 December 2020

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

1 reference

12 December 2020

TRAIL-induced apoptosis in human vascular endothelium is regulated by phosphatidylinositol 3-kinase/Akt through the short form of cellular FLIP and Bcl-2.

1 reference

12 December 2020

Critical roles of TRAIL in hepatic cell death and hepatic inflammation.

1 reference

12 December 2020

FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation.

1 reference

12 December 2020

Neuroprotection by a caspase inhibitor in acute bacterial meningitis

1 reference

12 December 2020

Expression of TRAIL and its receptors in human brain tumors

1 reference

12 December 2020

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

1 reference

12 December 2020

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

12 December 2020

The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival

1 reference

12 December 2020

Neuropathology of Human Immunodeficiency Virus Infection

1 reference

12 December 2020

Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis

1 reference

12 December 2020

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain

1 reference

12 December 2020

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

1 reference

12 December 2020

10.1007/S00109-009-0484-X

Identifiers

DOI

1 reference

20 August 2017

1 reference